“…Nasal congestion was reported in 95-100% of patients with CRSwNP in North America 17,27 , 73-88% of patients in Europe 34,35 , and 76-81% of patients in Asia 31,36 . Loss of smell was reported for 56-84% of patients with CRSwNP in North America 16,27 , 35-90% of patients in Europe 28,34,35,37,38 , and 30-100% of patients in Asia [30][31][32]36,39 . Sneezing was reported for 88% of patients in North America 26 , 12-73% of patients in Europe 28,34,35,38 , and 27-51% of patients in Asia 31,33 .…”